Sibutramine
Sibutramine comprising Serotonin and Norepinephrine (both compounds are very effective, norepinephrine gets into the body by the stress and pressure on fat loss, contrary to calm serotonin, thereby to suppress hunger). It is a drug for obese patients who have a history of cardiovascular disease and are unable to lose weight through diet and exe...
Sibutramine comprising Serotonin and Norepinephrine (both compounds are very effective, norepinephrine gets into the body by the stress and pressure on fat loss, contrary to calm serotonin, thereby to suppress hunger). It is a drug for obese patients who have a history of cardiovascular disease and are unable to lose weight through diet and exercise. It acts centrally in the brain, which generates a signal hunger. Sibutramine reduces appetite, thus increasing the feeling of satiety (but does not suppress appetite) and increase energy expenditure Sibutramine, along with a reduced calorie diet and exercise recommended for the treatment of obese patients with an initial body mass index (BMI) greater or equal to 30 kg / m2, or in patients with a BMI greater than or equal to 27 kg / m2 with other known risk factors such as diabetes type II or dyslipidemia. It has no addictive effects Psychostimulant
More

Sibutramine There are 4 products.

Sibutramine comprising Serotonin and Norepinephrine (both compounds are very effective, norepinephrine gets into the body by the stress and pressure on fat loss, contrary to calm serotonin, thereby to suppress hunger). It is a drug for obese patients who have a history of cardiovascular disease and are unable to lose weight through diet and exercise. It acts centrally in the brain, which generates a signal hunger. Sibutramine reduces appetite, thus increasing the feeling of satiety (but does not suppress appetite) and increase energy expenditure Sibutramine, along with a reduced calorie diet and exercise recommended for the treatment of obese patients with an initial body mass index (BMI) greater or equal to 30 kg / m2, or in patients with a BMI greater than or equal to 27 kg / m2 with other known risk factors such as diabetes type II or dyslipidemia. It has no addictive effects Psychostimulant

Showing 1 - 4 of 4 items